Febrile neutropenia:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | German |
Veröffentlicht: |
Berlin [u.a.]
Springer
1997
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | XV, 130 S. graph. Darst. |
ISBN: | 3540612300 |
Internformat
MARC
LEADER | 00000nam a2200000 c 4500 | ||
---|---|---|---|
001 | BV010828952 | ||
003 | DE-604 | ||
005 | 19970107 | ||
007 | t| | ||
008 | 960624s1997 gw d||| |||| 00||| ger d | ||
016 | 7 | |a 947290559 |2 DE-101 | |
020 | |a 3540612300 |c brosch. : ca. DM 38.00 |9 3-540-61230-0 | ||
035 | |a (OCoLC)34724349 | ||
035 | |a (DE-599)BVBBV010828952 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a ger | |
044 | |a gw |c DE | ||
049 | |a DE-355 |a DE-12 |a DE-578 | ||
050 | 0 | |a RC640.5 | |
082 | 0 | |a 616.1/54 |2 20 | |
084 | |a YC 2505 |0 (DE-625)153202:12911 |2 rvk | ||
084 | |a WH 200 |2 nlm | ||
245 | 1 | 0 | |a Febrile neutropenia |c J. A. Klastersky (ed.) |
264 | 1 | |a Berlin [u.a.] |b Springer |c 1997 | |
300 | |a XV, 130 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
650 | 4 | |a Antineoplastic Agents |x adverse effects |v Congresses | |
650 | 4 | |a Cancer |x Chemotherapy |x Complications | |
650 | 4 | |a Febrile neutropenia | |
650 | 4 | |a Fever |x chemically induced |v Congresses | |
650 | 4 | |a Neutropenia |x chemically induced |v Congresses | |
650 | 4 | |a Neutropenia |x therapy |v Congresses | |
650 | 0 | 7 | |a Antibiotikum |0 (DE-588)4002257-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Neutropenie |0 (DE-588)4267503-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Infektionskrankheit |0 (DE-588)4026879-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Fieber |0 (DE-588)4017064-0 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1995 |z Brüssel |2 gnd-content | |
689 | 0 | 0 | |a Neutropenie |0 (DE-588)4267503-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Neutropenie |0 (DE-588)4267503-0 |D s |
689 | 1 | 1 | |a Fieber |0 (DE-588)4017064-0 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
689 | 2 | 1 | |a Neutropenie |0 (DE-588)4267503-0 |D s |
689 | 2 | 2 | |a Infektionskrankheit |0 (DE-588)4026879-2 |D s |
689 | 2 | 3 | |a Antibiotikum |0 (DE-588)4002257-2 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Klastersky, Jean A. |e Sonstige |4 oth | |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007237648&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-007237648 |
Datensatz im Suchindex
_version_ | 1823607493720276992 |
---|---|
adam_text |
CONTENTS
CONTRIBUTORS
.
IX
HIGH-DOSE
CHEMOTHERAPY:
SAFER
AND
BETTER?
M.H.N.
T
ATTERSALL
.
1
BONE
MAROW
PROTECTORS
IN
CANCER
TREATMENT
P.C
ARDE
.
7
HEMATOPOIETIC
GROWTH
FACTORS
IN
FEBRILE
NEUTROPENIA
-
INDICATIONS
AND
LIMITATIONS
W.H
IDDEMANN
.
11
INCORPORATION
OF
QUALITY-OF-LIFE
CONSIDERATIONS
INTO
DECISIONS
MODEL
FOR
THE
USE
OF
COLONY-STIMULATING
FACTORS
IN
CHEMOTHERAPY
PATIENTS
AT
RISK
FOR
FEBRILE
NEUTROPENIA
G.H.
L
YMAN
,
N.M.K
UDERER
.
17
ASSESSING
RISK
IN
CANCER
PATIENTS
WITH
FEVER
AND
NEUTROPENIA
J.
A.
T
ALCOTT
.
23
THERAPEUTIC
APPROACH
IN
THE
AMBULATORY
SETTING,
FEASABILITY
AND
SURVEILLANCE
E.
B.
R
UBENSTEIN
.
29
THE
SEQUENCE
OF
INFECTIVE
EVENTS
IN
PROLONGED
NEUTROPENIA
B.
E.
D
E
P
AUW
.
35
THE
EMPIRICAL
THERAPEUTIC
CASCADE:
WHEN
TO
START
AND
WHEN
TO
STOP?
P.
A.
PIZZO
.
41
VIII
CONTENTS
TREATMENT
OF
NEUTROPENIC
INFECTION:
TRENDS
TOWARDS
MONOTHERAPY?
J.
A.
K
LASTERSKY
.
47
THE
CHANGING
SPECTRUM
OF
BACTERIAL
INFECTIONS
IN
FEBRILE
NEUTROPENIC
PATIENTS
K.
V.
I.
R
OLSTON
,
I.
R
AAD
,
E.
W
HIMBEY
,
AND
G.P.B
ODEY
53
SUSCEPTIBILITY
OF
STREPTOCOCCI
ISOLATED
FROM
BLOOD
OF
NEUTROPENIC
PATIENTS
TO
11
ANTIBIOTICS
D.
P
IERARD
,
A.
D
E
M
EYER
,
AND
S.
L
AUWERS
.
57
EMERGING
ANTIBIOTIC
RESISTANCE
IN
BACTERIAL
PATHOGENS
P.
M
OREILLON
.
59
CEFEPIME
VERSUS
CEFTAZIDIME
AS
EMPIRIC
THERAPY
OF
FEBRILE
EPISODES
IN
NEUTROPENIC
PATIENTS
J.
B
REEN
,
R.
R
AMPHAL
,
A.
C
OMETTA
,
B.
C
ONETTA
ANDC.NICAISE
.
63
CEFEPIME
VERSUS
CEFTAZIDIME
IN
THE
EMPIRIC
TREATMENT
OF
FEBRILE
NEUTROPENIC
CHILDREN
WITH
MALIGNANCY
M.
M.
M
USTAFA
.
75
CEFEPIME-VANCOMYCIN
VERSUS
CEFTAZIDIME-VANCOMYCIN
AS
EMPIRIC
THERAPY
IN
FEBRILE
NEUTROPENIC
PATIENTS
A.
B
OSLY
,
M.
A
OUN
,
M.
B
OOGAERTS
,
R.
S
CHOTS
AND
V.
D
E
P
RIL
.
77
MONOTHERAPY
WITH
MEROPENEM
VERSUS
COMBINATION
THERAPY
WITH
CEFTAZIDIME
PLUS
AMIKACIN
AS
EMPIRIC
THERAPY
FOR
FEVER
IN
GRANULOCYTOPENIC
PATIENTS
WITH
CANCER
A.
C
OMETTA
,
AND
THE
EORTC
I
NTERNATIONAL
A
NTIMICROBIAL
T
HERAPY
C
OOPERATIVE
G
ROUP
,
AND
THE
GIMEMA
I
NFECTION
P
ROGRAM
.
79
PIPERACILLIN
PLUS
TAZOBACTAM
VERSUS
CEFTAZIDIME
PLUS
AMIKACIN
IN
FEBRILE
NEUTROPENIA:
A
COMPARISON
IN
TERMS
OF
COST
AND
EFFICACY
T.
B
ERGHMANS
,
M.
A
OUN
,
AND
J.A.
K
LASTERSKY
.
85
FUNGAL
INFECTION
IN
NEUTROPENIC
PATIENTS:
PAST
ACHIVEMENTS
AND
FUTURE
PROBLEMS
G.P.B
ODEY
.
89
CONTENTS
IX
THE
PRESSURE
OF
EMERGING
RESISTANCE
IN
FUNGAL
DISEASES
B.
F.
D
UPONT
.
99
LIPOSOMAL
VERSUS
CONVENTIONAL
AMPHOTERICIN
B
FOR
THE
TREATMENT
OF
FEVER
OF
UNKNOWN
ORIGIN
IN
NEUTROPENIC
PATIENTS:
RESULTS
OF
TWO
RANDOMIZED
TRIALS
IN
204
CHILDREN
AND
134
ADULTS
C.
C.
K
IBBLER
AND
M
A
OUN
.
101
PULMONARY
INFILTRATE
ETIOLOGY
IN
LEUKEMIC
PATIENTS
WITH
FEVER
J.SKRICKOVA,J.MAYER,AND
J.VORLICEK
.
103
MARROW
TRANSPLANTATION:
CURRENT
RESULTS
AND
EFFECT
OF
IMMUNOGLOBULIN
PROPHYLAXIS
M.C.
W
ALTERS
.
107
THE
ROLE
OF
ECONOMIC
EVALUATION
IN
ASSESSING
THE
COST
OF
FEBRILE
NEUTROPENIA
T.
SZUCS
.
ILL
QUALITY
OF
LIFE
IN
PATIENTS
WITH
FEBRILE
NEUTROPENIA
R.F
ELD
.
117
SUBJECT
INDEX
.
125 |
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV010828952 |
callnumber-first | R - Medicine |
callnumber-label | RC640 |
callnumber-raw | RC640.5 |
callnumber-search | RC640.5 |
callnumber-sort | RC 3640.5 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | YC 2505 |
ctrlnum | (OCoLC)34724349 (DE-599)BVBBV010828952 |
dewey-full | 616.1/54 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.1/54 |
dewey-search | 616.1/54 |
dewey-sort | 3616.1 254 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV010828952</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19970107</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">960624s1997 gw d||| |||| 00||| ger d</controlfield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">947290559</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540612300</subfield><subfield code="c">brosch. : ca. DM 38.00</subfield><subfield code="9">3-540-61230-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)34724349</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV010828952</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">ger</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">DE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC640.5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.1/54</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 2505</subfield><subfield code="0">(DE-625)153202:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WH 200</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Febrile neutropenia</subfield><subfield code="c">J. A. Klastersky (ed.)</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XV, 130 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">adverse effects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield><subfield code="x">Complications</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Febrile neutropenia</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Fever</subfield><subfield code="x">chemically induced</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neutropenia</subfield><subfield code="x">chemically induced</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neutropenia</subfield><subfield code="x">therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Antibiotikum</subfield><subfield code="0">(DE-588)4002257-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Neutropenie</subfield><subfield code="0">(DE-588)4267503-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Fieber</subfield><subfield code="0">(DE-588)4017064-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1995</subfield><subfield code="z">Brüssel</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Neutropenie</subfield><subfield code="0">(DE-588)4267503-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Neutropenie</subfield><subfield code="0">(DE-588)4267503-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Fieber</subfield><subfield code="0">(DE-588)4017064-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Neutropenie</subfield><subfield code="0">(DE-588)4267503-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Infektionskrankheit</subfield><subfield code="0">(DE-588)4026879-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="3"><subfield code="a">Antibiotikum</subfield><subfield code="0">(DE-588)4002257-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Klastersky, Jean A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007237648&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007237648</subfield></datafield></record></collection> |
genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift 1995 Brüssel gnd-content |
genre_facet | Aufsatzsammlung Konferenzschrift 1995 Brüssel |
id | DE-604.BV010828952 |
illustrated | Illustrated |
indexdate | 2025-02-09T19:00:29Z |
institution | BVB |
isbn | 3540612300 |
language | German |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007237648 |
oclc_num | 34724349 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-12 DE-578 |
owner_facet | DE-355 DE-BY-UBR DE-12 DE-578 |
physical | XV, 130 S. graph. Darst. |
publishDate | 1997 |
publishDateSearch | 1997 |
publishDateSort | 1997 |
publisher | Springer |
record_format | marc |
spelling | Febrile neutropenia J. A. Klastersky (ed.) Berlin [u.a.] Springer 1997 XV, 130 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier Antineoplastic Agents adverse effects Congresses Cancer Chemotherapy Complications Febrile neutropenia Fever chemically induced Congresses Neutropenia chemically induced Congresses Neutropenia therapy Congresses Antibiotikum (DE-588)4002257-2 gnd rswk-swf Cytostatikum (DE-588)4068347-3 gnd rswk-swf Neutropenie (DE-588)4267503-0 gnd rswk-swf Infektionskrankheit (DE-588)4026879-2 gnd rswk-swf Fieber (DE-588)4017064-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content (DE-588)1071861417 Konferenzschrift 1995 Brüssel gnd-content Neutropenie (DE-588)4267503-0 s DE-604 Fieber (DE-588)4017064-0 s Cytostatikum (DE-588)4068347-3 s Infektionskrankheit (DE-588)4026879-2 s Antibiotikum (DE-588)4002257-2 s Klastersky, Jean A. Sonstige oth DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007237648&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Febrile neutropenia Antineoplastic Agents adverse effects Congresses Cancer Chemotherapy Complications Febrile neutropenia Fever chemically induced Congresses Neutropenia chemically induced Congresses Neutropenia therapy Congresses Antibiotikum (DE-588)4002257-2 gnd Cytostatikum (DE-588)4068347-3 gnd Neutropenie (DE-588)4267503-0 gnd Infektionskrankheit (DE-588)4026879-2 gnd Fieber (DE-588)4017064-0 gnd |
subject_GND | (DE-588)4002257-2 (DE-588)4068347-3 (DE-588)4267503-0 (DE-588)4026879-2 (DE-588)4017064-0 (DE-588)4143413-4 (DE-588)1071861417 |
title | Febrile neutropenia |
title_auth | Febrile neutropenia |
title_exact_search | Febrile neutropenia |
title_full | Febrile neutropenia J. A. Klastersky (ed.) |
title_fullStr | Febrile neutropenia J. A. Klastersky (ed.) |
title_full_unstemmed | Febrile neutropenia J. A. Klastersky (ed.) |
title_short | Febrile neutropenia |
title_sort | febrile neutropenia |
topic | Antineoplastic Agents adverse effects Congresses Cancer Chemotherapy Complications Febrile neutropenia Fever chemically induced Congresses Neutropenia chemically induced Congresses Neutropenia therapy Congresses Antibiotikum (DE-588)4002257-2 gnd Cytostatikum (DE-588)4068347-3 gnd Neutropenie (DE-588)4267503-0 gnd Infektionskrankheit (DE-588)4026879-2 gnd Fieber (DE-588)4017064-0 gnd |
topic_facet | Antineoplastic Agents adverse effects Congresses Cancer Chemotherapy Complications Febrile neutropenia Fever chemically induced Congresses Neutropenia chemically induced Congresses Neutropenia therapy Congresses Antibiotikum Cytostatikum Neutropenie Infektionskrankheit Fieber Aufsatzsammlung Konferenzschrift 1995 Brüssel |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=007237648&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT klasterskyjeana febrileneutropenia |